How long will Lupron work before prostate cancer becomes resistant?
After radiation my PC is considered incurable and I’m on Lupron for the rest of my life. I realize it will become less effective over time and just want some ideas about how long will the Lupron work. It is able to send my PSA back to .05. I get an injection in the belly every 3 months and after the third injection, Oncologist gave me a short break off the treatment. After three months off psa still .05. After six months off still .05. I just checked again after 9 months off and I’m now .39, a substantial increase from three months prior. I’m back on the Lupron and hoping it sends me back to where I was before the break. I guess since my Oncologist is hesitant to give any timing on all this, I would like to know how long before I have to add some other type of treatment to extend my life. No metastasis yet thankfully.
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
Great info and thanks. That helps me to see my case is very aggressive. I haven’t been under .94 in the 9months I’ve used the Lupron
Two and a half years ago, when I was first diagnosed, my oncologist did make a guess on how long ADT would keep my cancer castrate-sensitive based on his past experience, but the landscape has changed so fast that experience more than a couple of years old might no longer be valid. My onco team has since revised the number up a fair bit (I'm already past the original estimate and my PSA is still < 0.01 on the sensitive test).
Edit. My psa got as low as .04 not .94 like I said. Fat thumbs I guess
I am de novo stage 4 prostate cancer in bone only. I am getting a shot in my belly every 3 months with Eligard and I am taking 600mg Darolutamide (Nubeqa). In the ARSENS trial (triplet therapy) Darolutamide time to castrate resistance has not been reached. It has been over 5 years now.
Not to panic. It does take longer for the PSA to 'float' down with radiotherapy. The reason is that radio disrupts the cancer cell enzymes etc so it does not reproduce. It does not kill the cancer per se. It can as long as two years, apparently.
Dont mind me. I am just another layman trying to make some sense of the whole thing. Best consult your medical team, and if necessary second.
I see. Ignore my reply to your first.
The good news is the docs are not right. The down side is we are now in the grey area. They dont know, what they dont know.
Dont mind me. I am just another layman trying to make some sense of the whole thing.
Thank you all for the great info. One last question, my doc said incurable now since radiation failed. Do you all agree with that and things like salvage prostectomy, cryoblation, and Brachytherapy are off the table?
Remember that AIDS is also incurable, but people who are HIV-positive live to old age now because of drugs like AZT.
A recent Scientific American article suggested that stage 4 prostate cancer may soon be similar (if it's not there already): a chronic condition we manage, rather than a terminal illness. Current studies like IRONMAN are collecting the longevity data that will tell us
I understand your anxiety bruningk and empathize with you. Unless I missed it I didn't see anything about your staging. Where was the cancer located when you were scanned prior to going on ADT? I presume not confined to prostate? And what was the radiation field?
I've tried to understand the answer to this question and have come across several interesting facts, anecdotal evidence and opinions. Most of this is from memory from things I've read in studies or seen/heard oncos say at conferences or in youtube vids.
1. Disease burden matters. The more extensive the mets, the more mutated the cancer cells and less like the "mothership" they become. Thus they become less susceptible to drugs designed to starve cancer cells of the fuel, DHT or testosterone. I've spoken with guys who've had mets and have been battling PCa for many years, 25+ in one case. I think they had a relatively low, though advanced, disease burden when diagnosed.
2. PSA doubling time is a strong predictor of eventual metastasis and the subsequent transition to CRPC 2-3 years later (though you can become CR without metastatic disease). There is a point of inflection in the curve showing probability of developing distant mets versus PSADT. That occurs around a PSADT of 7 months and increases as PSA decreases further. My PSADT when my PSA took off after RP was around 8 months, so it was aggressive but possibly controllable over the long term. You should ask your onco what your calculated PSADT is based upon it shooting up from 0.05 to .39. There may be some nuances in the calculation I'm not aware of but on the surface it appears you have a pretty short PSADT. Of course this particular graph is probably not directly applicable to your question, but its a morsel of data.
3. Dr Mark Scholz made a very puzzling statement on one of his videos a couple of months ago regarding how long ADT treatments work. He didn't explain the exact context, but his comment was that these days with newer treatments the time to CR has been estimated to be around 17 years. I rewound the tape and relistened to it several times, but that was basically what he said. I'm not even sure how that is possible when the latest ARSIs have only been on the market about 5-7 years, though it is certainly possible to estimate parameters like that given data collected over a shorter period of time. I even called their (PCRI) support staff and asked about it but they had no answer.